526 related articles for article (PubMed ID: 33685103)
41. [Vaccination against SARS-CoV-2 in patients with multiple sclerosis].
Costa Frossard-França L; García-Domínguez JM; Moreno-Torres I; Fortún J; Villar LM; Meca-Lallana V
Rev Neurol; 2021 Apr; 72(7):250-260. PubMed ID: 33764494
[TBL] [Abstract][Full Text] [Related]
42. The world's largest COVID-19 vaccination campaign.
Bagcchi S
Lancet Infect Dis; 2021 Mar; 21(3):323. PubMed ID: 33639124
[No Abstract] [Full Text] [Related]
43. India begins COVID-19 vaccination amid trial allegations.
Bhuyan A
Lancet; 2021 Jan; 397(10271):264. PubMed ID: 33485435
[No Abstract] [Full Text] [Related]
44. A Call to Arms: The War of the COVID.
Alpert JS; Boylston AW
Am J Med; 2021 Apr; 134(4):413-414. PubMed ID: 33385338
[No Abstract] [Full Text] [Related]
45. Africa's need for more COVID-19 clinical trials.
Makoni M
Lancet; 2021 May; 397(10289):2037. PubMed ID: 34062137
[No Abstract] [Full Text] [Related]
46. Vaccinating children: fairness and childism.
Autzen B; Dineen K; Vaughan D
Lancet Infect Dis; 2021 Oct; 21(10):1354-1355. PubMed ID: 34399089
[No Abstract] [Full Text] [Related]
47. Equitable access to COVID-19 vaccination: a distant dream?
Lomazzi M; De Sousa L; Amofah G; Ricciardi W
Eur J Public Health; 2020 Dec; 30(6):1039-1040. PubMed ID: 33027515
[No Abstract] [Full Text] [Related]
48. Lessons from the United Kingdom's COVID-19 vaccination strategy.
Harnden A; Earnshaw A
Med J Aust; 2021 May; 214(9):417-419. PubMed ID: 33893643
[No Abstract] [Full Text] [Related]
49. The COVID antivaccination dilemma.
Pederson T
FASEB J; 2021 Nov; 35(11):e21953. PubMed ID: 34591331
[No Abstract] [Full Text] [Related]
50. Vaccine Hesitancy and COVID-19: Nursing's Role.
Enriquez M
Hisp Health Care Int; 2021 Jun; 19(2):74. PubMed ID: 33984251
[No Abstract] [Full Text] [Related]
51. The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials.
Rid A; Lipsitch M; Miller FG
JAMA; 2021 Jan; 325(3):219-220. PubMed ID: 33315080
[No Abstract] [Full Text] [Related]
52. Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases.
Furer V; Rondaan C; Agmon-Levin N; van Assen S; Bijl M; Kapetanovic MC; de Thurah A; Mueller-Ladner U; Paran D; Schreiber K; Warnatz K; Wulffraat NM; Elkayam O
RMD Open; 2021 Feb; 7(1):. PubMed ID: 33627440
[TBL] [Abstract][Full Text] [Related]
53. Status of vaccine development for COVID-19.
Mendes A
Br J Community Nurs; 2020 Dec; 25(12):620-621. PubMed ID: 33275511
[No Abstract] [Full Text] [Related]
54. Thrombosis with thrombocytopenia syndrome after COVID-19 vaccination.
Cuker A
Clin Adv Hematol Oncol; 2021 Jul; 19(7):446-449. PubMed ID: 34236343
[No Abstract] [Full Text] [Related]
55. Feelings towards COVID-19 vaccination in Africa.
Samarasekera U
Lancet Infect Dis; 2021 Mar; 21(3):324. PubMed ID: 33639125
[No Abstract] [Full Text] [Related]
56. Should children be vaccinated against COVID-19 now?
Wong BLH; Ramsay ME; Ladhani SN
Arch Dis Child; 2021 Dec; 106(12):1147-1148. PubMed ID: 33402324
[No Abstract] [Full Text] [Related]
57. Intradermal covid-19 vaccination could solve supply problems.
Schweiger M
BMJ; 2021 Aug; 374():n1980. PubMed ID: 34400478
[No Abstract] [Full Text] [Related]
58. Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit?
Garvey LH; Nasser S
Br J Anaesth; 2021 Mar; 126(3):e106-e108. PubMed ID: 33386124
[No Abstract] [Full Text] [Related]
59. The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy.
Ortega Rodríguez NR; Audícana Berasategui MT; de la Hoz Caballer B; Valero Santiago A
J Investig Allergol Clin Immunol; 2021 Feb; 31(1):89-91. PubMed ID: 33393485
[No Abstract] [Full Text] [Related]
60. COVID-19 vaccines approved in the European Union: current evidence and perspectives.
Bellino S
Expert Rev Vaccines; 2021 Oct; 20(10):1195-1199. PubMed ID: 34338126
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
